Kelly Elizabeth Mccann

Title(s)HS Assistant Clinical Professor, Medicine
SchoolMedicine
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Selection of appropriate biomarkers to monitor effectiveness of ovarian function suppression in pre-menopausal patients with ER+ breast cancer. NPJ Breast Cancer. 2024 Jan 19; 10(1):8. McCann KE, Goldfarb SB, Traina TA, Regan MM, Vidula N, Kaklamani V. PMID: 38242892; PMCID: PMC10798954.
      View in: PubMed   Mentions:
    2. Updates in the treatment of HR+HER2- breast cancer. Curr Opin Obstet Gynecol. 2024 Feb 01; 36(1):57-63. Baclig NV, McCann KE. PMID: 38170552.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Clinical Significance of Background Parenchymal Enhancement in Breast Cancer Risk Stratification. J Magn Reson Imaging. 2023 Sep 19. Murakami W, Mortazavi S, Yu T, Kathuria-Prakash N, Yan R, Fischer C, McCann KE, Lee-Felker S, Sung K. PMID: 37724902.
      View in: PubMed   Mentions:    Fields:    
    4. Preclinical and Clinical Trial Results Using Talazoparib and Low-Dose Chemotherapy. Clin Cancer Res. 2023 01 04; 29(1):40-49. Wainberg ZA, Singh AS, Konecny GE, McCann KE, Hecht JR, Goldman J, Chmielowski B, Finn RS, O'Brien N, Von Euw E, Price MM, Martinez D, Yonemoto L, Brennan M, Glaspy JA, Slamon DJ. PMID: 36136304.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    5. Quantitative Predictors of Response to Neoadjuvant Chemotherapy on Dynamic Contrast-enhanced 3T Breast MRI. J Breast Imaging. 2022 Apr 15; 4(2):168-176. Murakami W, Won Choi H, Joines MM, Hoyt A, Doepke L, McCann KE, Salamon N, Sayre J, Lee-Felker S. PMID: 38422427.
      View in: PubMed   Mentions:
    6. End-of-life transitions for family member on the solid tumour oncology ward: the 3 Wishes Project. BMJ Support Palliat Care. 2021 Sep 01. Day G, Bear D, Swinton M, Karlin D, Phung P, McCann K, Bell A, McParlane R, Granone MC, Cook DJ, Neville TH. PMID: 34470773.
      View in: PubMed   Mentions: 1     Fields:    
    7. Epigenetic Regulation of Immunotherapy Response in Triple-Negative Breast Cancer. Cancers (Basel). 2021 Aug 17; 13(16). Llinàs-Arias P, Íñiguez-Muñoz S, McCann K, Voorwerk L, Orozco JIJ, Ensenyat-Mendez M, Sesé B, DiNome ML, Marzese DM. PMID: 34439290; PMCID: PMC8394958.
      View in: PubMed   Mentions: 4  
    8. Innovations in targeted therapies for triple negative breast cancer. Curr Opin Obstet Gynecol. 2021 02 01; 33(1):34-47. McCann KE, Hurvitz SA. PMID: 33093337.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    9. Advances in Targeted Therapies for Triple-Negative Breast Cancer. Drugs. 2019 Jul; 79(11):1217-1230. McCann KE, Hurvitz SA, McAndrew N. PMID: 31254268.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    10. Advances in the use of PARP inhibitors for BRCA1/2-associated breast cancer: talazoparib. Future Oncol. 2019 May; 15(15):1707-1715. McCann KE. PMID: 30912451.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    11. Poly-ADP-ribosyl-polymerase inhibitor resistance mechanisms and their therapeutic implications. Curr Opin Obstet Gynecol. 2019 02; 31(1):12-17. McCann KE. PMID: 30540581.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    12. Advances in the use of PARP inhibitor therapy for breast cancer. Drugs Context. 2018; 7:212540. McCann KE, Hurvitz SA. PMID: 30116283; PMCID: PMC6089618.
      View in: PubMed   Mentions: 54  
    13. Harnessing the immune system in the battle against breast cancer. Drugs Context. 2018; 7:212520. Nakasone ES, Hurvitz SA, McCann KE. PMID: 29456568; PMCID: PMC5810622.
      View in: PubMed   Mentions: 17  
    14. Novel poly-ADP-ribose polymerase inhibitor combination strategies in ovarian cancer. Curr Opin Obstet Gynecol. 2018 Feb; 30(1):7-16. McCann KE. PMID: 29251678.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    15. Biochemical, Molecular, and Clinical Characterization of Succinate Dehydrogenase Subunit A Variants of Unknown Significance. Clin Cancer Res. 2017 Nov 01; 23(21):6733-6743. Bannon AE, Kent J, Forquer I, Town A, Klug LR, McCann K, Beadling C, Harismendy O, Sicklick JK, Corless C, Shinde U, Heinrich MC. PMID: 28724664; PMCID: PMC6011831.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    16. A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis. Science. 2009 Jan 30; 323(5914):644-8. Venteicher AS, Abreu EB, Meng Z, McCann KE, Terns RM, Veenstra TD, Terns MP, Artandi SE. PMID: 19179534; PMCID: PMC2728071.
      View in: PubMed   Mentions: 291     Fields:    Translation:HumansCells
    17. Radiosensitization of yeast cells by inhibition of histone h4 acetylation. Radiat Res. 2008 Nov; 170(5):618-627. Song S, McCann KE, Brown JM. PMID: 18959465; PMCID: PMC2588468.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    18. A role for Lsmlp in response to ultraviolet-radiation damage in Saccharomyces cerevisiae. Radiat Res. 2008 Oct; 170(4):411-21. Spicakova T, McCann K, Brown JM. PMID: 19024647; PMCID: PMC2597385.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    19. Global analysis of gene function in yeast by quantitative phenotypic profiling. Mol Syst Biol. 2006; 2:2006.0001. Brown JA, Sherlock G, Myers CL, Burrows NM, Deng C, Wu HI, McCann KE, Troyanskaya OG, Brown JM. PMID: 16738548; PMCID: PMC1681475.
      View in: PubMed   Mentions: 73     Fields:    Translation:AnimalsCells
    With one click, see people who:

    Run Clinical Trials

    See more options in the Advanced Search tab

    Kelly's Networks
    Concepts (71)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (17)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California